Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor cell membrane, when targeted by hyperthermia-induced cytotoxicity, refers to the plasma membrane of cancer cells as the site where heat-based therapies exert their effects. Hyperthermia involves raising tissue temperatures (typically 39–45 °C) to induce cell death through apoptosis or necrosis, exploiting the increased sensitivity of tumor cells to elevated temperatures. The mechanism of action involves membrane disruption, oxidative stress, apoptosis induction and enhanced drug delivery. Selectivity for tumor cells over normal cells occurs due to poorer blood flow and more acidic/hypoxic microenvironments.
Physical disruption of the cell membrane via heat, leading to increased permeability, oxidative stress, and induction of apoptosis or necrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Membrane via Hyperthermia-Induced Cytotoxicity.